Exelixis
EXEL
#1759
Rank
$11.85 B
Marketcap
$44.04
Share price
-0.25%
Change (1 day)
22.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company